Koninklijke Philips N.V. EV/EBITDA Ratio 2011-2026 | PHG

Annual EV/EBITDA Ratio Koninklijke Philips N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
55.6	16.9	15.4	13.7	15.8	13.3	19.3	28.4	10	10.7	27.2

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
55.6	10	20.6

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Agilent Technologies A	27.4	$ 115.48	0.82 %	$ 35.1 B	USA
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	-1.51	$ 16.2	-0.61 %	$ 175 M	China
Biodesix BDSX	-4.25	$ 15.07	2.1 %	$ 1.95 B	USA
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 5.85 M	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Castle Biosciences CSTL	-21.2	$ 24.84	-0.84 %	$ 690 M	USA
DarioHealth Corp. DRIO	-1.05	$ 8.4	3.7 %	$ 33.5 M	Israel
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
BioNano Genomics BNGO	-7.71	$ 1.2	0.84 %	$ 6.53 M	USA
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Charles River Laboratories International CRL	22	$ 173.89	-0.58 %	$ 8.62 B	USA
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
DexCom DXCM	39.5	$ 62.22	-0.24 %	$ 24.3 B	USA
Fulgent Genetics FLGT	2.58	$ 16.82	2.31 %	$ 509 M	USA
Biomerica BMRA	-6.24	$ 2.17	-0.91 %	$ 4.98 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Celcuity CELC	-2.38	$ 112.63	-0.27 %	$ 5.27 B	USA
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	5.51	$ 198.02	0.17 %	$ 22 B	USA
Guardant Health GH	-28.8	$ 93.83	2.94 %	$ 11.8 B	USA
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	-187	$ 76.1	0.53 %	$ 5.14 B	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
Medpace Holdings MEDP	30.7	$ 498.34	1.81 %	$ 14.4 B	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	-6.02	$ 1.96	5.82 %	$ 8.67 M	USA
Mettler-Toledo International MTD	827	$ 1 259.94	-1.11 %	$ 26 B	Schweiz
ICON Public Limited Company ICLR	38	$ 114.19	2.49 %	$ 9.42 B	Irlanda
IDEXX Laboratories IDXX	45.3	$ 569.55	0.87 %	$ 45.8 B	USA
Neogen Corporation NEOG	40.3	$ 9.41	0.21 %	$ 2.04 B	USA
Illumina ILMN	70.5	$ 127.38	0.59 %	$ 20.3 B	USA
IQVIA Holdings IQV	24.1	$ 173.26	0.5 %	$ 29.8 B	USA
Pacific Biosciences of California PACB	-23.8	$ 1.34	-0.74 %	$ 402 M	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 273.72	0.36 %	$ 22.8 B	USA
Myriad Genetics MYGN	-17.2	$ 4.75	3.49 %	$ 440 M	USA
Sotera Health Company SHC	24.8	$ 14.96	0.61 %	$ 4.25 B	USA
NeoGenomics NEO	-33.5	$ 8.0	3.23 %	$ 1.02 B	USA
National Research Corporation NRC	21	$ 17.16	-1.04 %	$ 384 M	USA